Guideline-based treatment of recurrent/metastatic cervical cancer

touchEXPERT OPINIONS for touchONCOLOGY  Two oncologists summarize the latest US and European guidelines for the treatment of recurrent/metastatic cervical cancer and a nurse practitioner considers key safety considerations for immunotherapy and targeted treatments. The experts Dr David O’Malley - James Comprehensive Cancer Center, Columbus, OH, USA Dr Domenica Lorusso - La Fondazione Policlinico Universitario Agostino Gemelli, Rome, Italy, Courtney Arn – The Ohio State University, Columbus, OH, USA This touchPODCAST is for HCPs only.  This activity is funded by an independent medical educational grant from Merck and Co., Inc and Seagen Inc. This activity is jointly provided by USF Health and touchIME. For further information visit our website: touchoncologyime.org/guideline-management-recurrent-metastatic-cervical-cancer